Is Indrayani Biotech a good stock to invest in?

Indrayani Biotech can be analyzed on the following key metrics - TTM P/E: - Sector P/E: 38.02 Dividend Yield: 0% D/E ratio: -

Indrayani Biotech Share Price

Sector: Hotels & Motels

Powered by

13.90 +0.17 (1.24%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 13.46

Today’s High 14.09

52 Week Low 13.01

52 Week High 62.71

Key Metrics

Market Cap (In Cr) 62.57
Beta 1.21
Div. Yield (%) 0
P/B 0.87
TTM P/E -
Sector P/E 38.02
D/E 0.02
Open Price 13.79
Prev Close 13.73

View All Metrics

Indrayani Biotech Analysis

Price Analysis

1 Week

-1.56%
3 Months

-2.81%
6 Month

-61.42%
YTD

-61.75%
1 Year

-77.01%

Risk Meter

48% Low risk
48% Moderate risk
48% Balanced Risk
48% High risk
48% Extreme risk

Indrayani Biotech News

Premium

₹3.50 to ₹45.50: Penny stock turns multibagger. Rises 1200% in seven years

1 min read . 06 Nov 2024

View More News

Indrayani Biotech Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
130.23

Selling/ General/ Admin Expenses Total
20.47

Depreciation/ Amortization
3.37

Other Operating Expenses Total
20.73

Total Operating Expense
127.34

Operating Income
2.89

Net Income Before Taxes
-5.74

Net Income
-6.11

Diluted Normalized EPS
-1.35

Period
2024

Total Revenue
166.23

Selling/ General/ Admin Expenses Total
31.09

Depreciation/ Amortization
3.8

Other Operating Expenses Total
7.65

Total Operating Expense
146.37

Operating Income
19.86

Net Income Before Taxes
10.97

Net Income
10.42

Diluted Normalized EPS
2.68

Period
2023

Total Revenue
162.93

Selling/ General/ Admin Expenses Total
23.54

Depreciation/ Amortization
3.35

Other Operating Expenses Total
19.95

Total Operating Expense
149.55

Operating Income
13.38

Net Income Before Taxes
12.31

Net Income
11.93

Diluted Normalized EPS
2.86

Period
2022

Total Revenue
61.57

Selling/ General/ Admin Expenses Total
12.65

Depreciation/ Amortization
0.66

Other Operating Expenses Total
0.76

Total Operating Expense
55.45

Operating Income
6.12

Net Income Before Taxes
4.46

Net Income
4.46

Diluted Normalized EPS
1.3

Period
2021

Total Revenue
21.09

Selling/ General/ Admin Expenses Total
9.79

Depreciation/ Amortization
0.46

Other Operating Expenses Total
0.14

Total Operating Expense
26.49

Operating Income
-5.4

Net Income Before Taxes
-11.22

Net Income
-11.22

Diluted Normalized EPS
-3.28

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Indrayani Biotech Technical

Moving Average SMA

5 Day13.8
10 Day14.23
20 Day14.96

50 Day16.33
100 Day18.86
300 Day29.16

Indrayani Biotech Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Royale Manor Hotels And Indust
49.43
-1.01
-2
65
35.33
98.03

Jindal Hotels
93.89
1.58
1.71
141.35
81
65.73

Indrayani Biotech
13.9
0.17
1.24
62.71
13.01
62.57

Blue Coast Hotels
31.36
-0.63
-1.97
51.42
6.65
45.91

West Leisure Resorts
154.9
0
0
273.4
118.65
47.3

Indrayani Biotech Shareholding

Shareholding Pattern

*Promoter pledging: 8.19%

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

12-Jun-25
Audited Results

09-Jun-25
Audited Results

03-Apr-25
Rights issue of Equity Shares

27-Feb-25
Quarterly Results

14-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results & Rights issue

14-Aug-24
Quarterly Results

27-Jul-24
Others

30-May-24
Audited Results

10-Feb-24
Quarterly Results

Meeting Date
Announced on
Purpose

22-Aug-24
29-Jul-24
AGM

16-Feb-24
15-Jan-24
POM

20-Sept-23
30-Aug-23
AGM

25-Apr-22
28-Mar-22
EGM

30-Sept-19
31-Aug-19
AGM

View All

Company Profile

ABOUT Indrayani Biotech

Industry Hotels & Motels
ISIN INE007C01021
BSE Code 526445

Indrayani Biotech Limited is engaged in the business operations of food and hospitality, dairy, healthcare and pharmaceutical, engineering, biotechnology, agriculture, and infrastructure. It provides a full range of food supply services on a contract basis to colleges and universities, hospitals and healthcare institutions, corporate offices, industries, among others. It markets and sells microorganism-based bio fertilizers, bio-pest controllers, bio-fortified vermi compost and bio-fortified coirpith to farmers. Its dairy unit offers skimmed milk powder, milk protein concentrates, milk whey powder, whey powder, whey protein concentrates, evaporated milk, whole milk powder, dairy whitener and casein. It operates hospitals, clinics, pharma companies, and pharma marketing companies. It is also engaged in corporate farming and trades agricultural commodities for the group's companies and external entities. It promotes commercial and residential infrastructure projects.

MANAGEMENT

Dhinakaran Rajagopal Chief Financial Officer
Kasiraman Sundar Managing Director, Executive Director
Singarababu Indirakumkar Wholetime Director
Muthukrishnan Ramesh Wholetime Director
G. Swaminathan Wholetime Director

INDRAYANI BIOTECH SUMMARY

Indrayani Biotech is trading 1.24% upper at Rs 13.90 as compared to its last closing price. Indrayani Biotech has been trading in the price range of 14.09 & 13.46. Indrayani Biotech has given -61.75% in this year & -1.56% in the last 5 days.

The company posted a net profit of -8.53 Crores in its last quarter.

Listed peers of Indrayani Biotech include Royale Manor Hotels And Indust (-2%), Jindal Hotels (1.71%), Indrayani Biotech (1.24%) etc.

Indrayani Biotech has a 33.28% promoter holding & 66.72% public holding.

FAQs about Indrayani Biotech

Indrayani Biotech is trading at 13.90 as on 27 Jun, 2025 3:29:19 PM. This is 1.24% upper as compared to its previous closing price of 13.73

The market capitalization of Indrayani Biotech is 62.57 Cr as on 27 Jun, 2025 3:29:19 PM.

The 52 wk high for Indrayani Biotech is 62.71 whereas the 52 wk low is 13.01

Indrayani Biotech can be analyzed on the following key metrics -

TTM P/E: -
Sector P/E: 38.02
Dividend Yield: 0%
D/E ratio: -

Indrayani Biotech reported a net profit of -6.11 Cr in 2025.

Indrayani Biotech Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Indrayani Biotech Share Price

Price Range

Key Metrics

Indrayani Biotech Analysis

Indrayani Biotech News

₹3.50 to ₹45.50: Penny stock turns multibagger. Rises 1200% in seven years

Indrayani Biotech Financials

Forecast

Forecast

Forecast

Indrayani Biotech Technical

Indrayani Biotech Peers

Indrayani Biotech Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Indrayani Biotech

MANAGEMENT

INDRAYANI BIOTECH SUMMARY

FAQs about Indrayani Biotech

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue